Minister of Innovation, Science, and Industry François-Philippe Champagne announced that more than $500 million in funding will go towards cancer research support through the Canadian Foundation of Innovation.
The Canadian Cancer Trials Group, (CCTG) located at Queen’s University, was one of 102 recipients, receiving over $5 million in funding.
CCTG leads the cancer research project ExCELLirate Canada, and in a statement released by the group, said the money received will go towards national research for development of new cancer cell therapies.
In the statement, Dr. Annette Hay, project co-lead and senior investigator at the CCTG says, “Cell therapies are demonstrating meaningful and lifesaving remissions for some people in whom chemotherapy and stem cell transplants have not yet worked.
“However, the current costs and access to these treatments are an issue.”
Get weekly health news
The cancer research group was unavailable for comment when directly contacted by Global News.
- Pope Francis says medically-assisted dying is ‘false compassion’
- Death of pregnant woman and her baby prompts call for Saskatchewan rural health changes
- Police, fire or ambulance? Winnipeg launching 4th option for 911 mental health calls
- Over 10K of these fridges have been recalled in Canada for risk of fire
CCTG says this infrastructure award will address current gaps in cell therapy development at ExCELLirate Canada sites located in Kingston, Hamilton, Ottawa, Montreal, and Calgary.
Comments
Want to discuss? Please read our Commenting Policy first.